Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Considerations for Formulating the Second-Generation Pneumococcal Capsular Polysaccharide Vaccine with Emphasis on the Cross-Reactive Types Within Groups

Considerations for Formulating the Second-Generation Pneumococcal Capsular Polysaccharide Vaccine... THE JOURNAL OF INFECfIOUS DISEASES • VOL. 148, NO.6. DECEMBER 1983 Considerations for Formulating the Second-Generation Pneumococcal Capsular Polysaccharide Vaccine with Emphasis on the Cross-Reactive 'Iypes Within Groups J. B. Robbins, R. Austrian, c-a Lee, S. C. Rastogi, From the Office of Biologics, Food and Drug Administration, Bethesda, Maryland; the Department of G. Schiffman, J. Henrichsen, ~ H. Makela, Research Medicine, University of Pennsylvania School of c. V. Broome, R. R. Facklam, R. H. Tiesjema, and Medicine, Philadelphia, Pennsylvania; the Department of J. C. Parke, Jr Microbiology, State University of New York Downstate Medical Center, Brooklyn, New York,' the World Health Organization Collaborating Center for Reference and Research on Pneumococci; Statens Seruminstitut, Copenhagen, Denmark; the Central Public Health Laboratory, State Serum Institute, Helsinki; Finland,' the Respiratory and Special Pathogens Branch, Center for Infectious Diseases, Centers for Disease Control, Atlanta, Georgia; the Rijks Instituut voor de Volksgezondheid, Bilthoven; the Netherlands; and the Department of Pediatrics, Charlotte Memorial Hospital, Charlotte, North Carolina There are several reasons for the resurgence of in­ United States [12]. These workers estimated a terest in the prevention of diseases caused by pneu­ minimal attack rate of pneumococcal pneumonia mococci. Even when treated with antibiotics, to be http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Journal of Infectious Diseases Oxford University Press

Considerations for Formulating the Second-Generation Pneumococcal Capsular Polysaccharide Vaccine with Emphasis on the Cross-Reactive Types Within Groups

Loading next page...
 
/lp/oxford-university-press/considerations-for-formulating-the-second-generation-pneumococcal-v5e3SOUpaL

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Oxford University Press
Copyright
© Published by Oxford University Press.
ISSN
0022-1899
eISSN
1537-6613
DOI
10.1093/infdis/148.6.1136
Publisher site
See Article on Publisher Site

Abstract

THE JOURNAL OF INFECfIOUS DISEASES • VOL. 148, NO.6. DECEMBER 1983 Considerations for Formulating the Second-Generation Pneumococcal Capsular Polysaccharide Vaccine with Emphasis on the Cross-Reactive 'Iypes Within Groups J. B. Robbins, R. Austrian, c-a Lee, S. C. Rastogi, From the Office of Biologics, Food and Drug Administration, Bethesda, Maryland; the Department of G. Schiffman, J. Henrichsen, ~ H. Makela, Research Medicine, University of Pennsylvania School of c. V. Broome, R. R. Facklam, R. H. Tiesjema, and Medicine, Philadelphia, Pennsylvania; the Department of J. C. Parke, Jr Microbiology, State University of New York Downstate Medical Center, Brooklyn, New York,' the World Health Organization Collaborating Center for Reference and Research on Pneumococci; Statens Seruminstitut, Copenhagen, Denmark; the Central Public Health Laboratory, State Serum Institute, Helsinki; Finland,' the Respiratory and Special Pathogens Branch, Center for Infectious Diseases, Centers for Disease Control, Atlanta, Georgia; the Rijks Instituut voor de Volksgezondheid, Bilthoven; the Netherlands; and the Department of Pediatrics, Charlotte Memorial Hospital, Charlotte, North Carolina There are several reasons for the resurgence of in­ United States [12]. These workers estimated a terest in the prevention of diseases caused by pneu­ minimal attack rate of pneumococcal pneumonia mococci. Even when treated with antibiotics, to be

Journal

The Journal of Infectious DiseasesOxford University Press

Published: Dec 1, 1983

There are no references for this article.